DE69317931T2 - Sensibilisierte Erythrozyten, ein Verfahren zu deren Herstellung, und deren Verwendung - Google Patents

Sensibilisierte Erythrozyten, ein Verfahren zu deren Herstellung, und deren Verwendung

Info

Publication number
DE69317931T2
DE69317931T2 DE69317931T DE69317931T DE69317931T2 DE 69317931 T2 DE69317931 T2 DE 69317931T2 DE 69317931 T DE69317931 T DE 69317931T DE 69317931 T DE69317931 T DE 69317931T DE 69317931 T2 DE69317931 T2 DE 69317931T2
Authority
DE
Germany
Prior art keywords
sensitized erythrocytes
preparation
antiglobulin
relates
intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69317931T
Other languages
English (en)
Other versions
DE69317931D1 (de
Inventor
Nee Wartell Mannessier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Francais du Sang Ets
Original Assignee
AETSRN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AETSRN filed Critical AETSRN
Publication of DE69317931D1 publication Critical patent/DE69317931D1/de
Application granted granted Critical
Publication of DE69317931T2 publication Critical patent/DE69317931T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69317931T 1992-02-24 1993-02-01 Sensibilisierte Erythrozyten, ein Verfahren zu deren Herstellung, und deren Verwendung Expired - Lifetime DE69317931T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9202081A FR2687788B1 (fr) 1992-02-24 1992-02-24 Materiel pour la mise en evidence en phase solide, de complexes antigenes-anticorps par des hematies indicatrices sa methode de preparation et son utilisation.

Publications (2)

Publication Number Publication Date
DE69317931D1 DE69317931D1 (de) 1998-05-20
DE69317931T2 true DE69317931T2 (de) 1998-10-22

Family

ID=9426935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69317931T Expired - Lifetime DE69317931T2 (de) 1992-02-24 1993-02-01 Sensibilisierte Erythrozyten, ein Verfahren zu deren Herstellung, und deren Verwendung

Country Status (6)

Country Link
EP (1) EP0558361B1 (de)
AT (1) ATE165167T1 (de)
DE (1) DE69317931T2 (de)
DK (1) DK0558361T3 (de)
ES (1) ES2117108T3 (de)
FR (1) FR2687788B1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163640A1 (de) * 2001-12-21 2003-07-03 Arno Kromminga Nachweis von Wechselwirkungen zwischen mindestens zwei spezifischen Biomolekülen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247536A (en) * 1978-03-20 1981-01-27 American Hospital Supply Corporation Method of preparing C3-sensitized erythrocytes
GB2117514B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Polyvalent antiglobulin reagent
EP0363510B1 (de) * 1988-10-12 1993-12-15 Biotest AG Verfahren zur Suche und Identifizierung von erythrozytären Antikörpern mit Hilfe der Festphasen-Methode

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163640A1 (de) * 2001-12-21 2003-07-03 Arno Kromminga Nachweis von Wechselwirkungen zwischen mindestens zwei spezifischen Biomolekülen

Also Published As

Publication number Publication date
DK0558361T3 (da) 1999-02-08
ATE165167T1 (de) 1998-05-15
EP0558361B1 (de) 1998-04-15
ES2117108T3 (es) 1998-08-01
DE69317931D1 (de) 1998-05-20
FR2687788A1 (fr) 1993-08-27
FR2687788B1 (fr) 1994-12-30
EP0558361A1 (de) 1993-09-01

Similar Documents

Publication Publication Date Title
Branch et al. A new reagent (ZZAP) having multiple applications in immunohematology
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ATE86739T1 (de) Diagnostischer testtraeger und verfahren zu dessen herstellung.
DE3265080D1 (en) Creatinine antibody
AU7727491A (en) Improvements in or relating to methods for providing internal references for use in analyte-receptor assays
AU3386089A (en) Polypeptide-induced monoclonal antibodies to oncoproteins
EP0203968A4 (de) Immunoanalysetestverfahren für cholesterolepoxide.
EP0058780A1 (de) Antigen/Antikörper-Bestimmungsmethode
DK603087D0 (da) Immunokemisk metod tilbestemmelse af stabilt glycosyleret haemoglobin
SE8004815L (sv) Bestemning av endstaende sackaridgrupper i glykoprotein
ATE188746T1 (de) Adeno-assozierter virus - dessen diagnostischen anwendung für frühe abtreibung
DE69317931T2 (de) Sensibilisierte Erythrozyten, ein Verfahren zu deren Herstellung, und deren Verwendung
JPS6428560A (en) Immunometric measurement
NO874453L (no) Fremgangsmaate til bestemmelse av anti-hiv, middel dertil og dets anvendelse i fremgangsmaaten.
DE59108366D1 (de) Verfahren zur Bestimmung eines Analyten
ATE50459T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
DE59207717D1 (de) Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz
EP0444787A3 (en) Monoclonal antibodies against non-a 1c glycated hemoglobin
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
KR960706073A (ko) 혈액성분의 검출방법 및 이에 사용하는 킷트
DE68927199D1 (de) Immuntest
YU45749B (sh) Brzo dijagnostičko sredstvo za sortiranje krvi i postupak za njegovo pravljenje
McGinniss et al. Evidence for two anomalous I blood group determinants
Lang et al. Rabbit erythrocyte hemagglutinins in schizophrenia
DD273050A1 (de) Verfahren zur gewinnung von praeparaten nitrifizierender bakterien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ETABLISSEMENT FRANCAIS DU SANG, LA PLAINE SAIN, FR

8328 Change in the person/name/address of the agent

Representative=s name: CABINET HIRSCH & ASSOCIES, PARIS, FR